Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of Mortality-Reference-Cited by-同舟云学术

Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of Mortality

Published:2017-12-01 Issue:12 Volume:3 Page:1675
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Sorror Mohamed L.¹²,Storer Barry E.³⁴,Fathi Amir T.⁵,Gerds Aaron T.⁶,Medeiros Bruno C.⁷,Shami Paul⁸,Brunner Andrew M.⁵,Sekeres Mikkael A.⁶,Mukherjee Sudipto⁶,Peña Esteban⁸,Elsawy Mahmoud¹⁹,Wardyn Shylo³,Whitten Jennifer³,Moore Rachelle¹,Becker Pamela S.¹²,McCune Jeannine S.¹,Appelbaum Frederick R.¹²,Estey Elihu H.²

Affiliation:

1. Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle

2. Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle

3. Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington School of Public Health, Seattle

4. Department of Biostatistics, University of Washington School of Public Health, Seattle

5. Massachusetts General Hospital, Harvard Medical School, Boston

6. Leukemia & Myeloid Disorders Program, Cleveland Clinic, Cleveland, Ohio

7. Department of Medicine, Division of Hematology, Stanford University, Stanford, California

8. Huntsman Cancer Institute, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City

9. Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

http:///jamaoncology/article-pdf/3/12/1675/17684833/jamaoncology_sorror_2017_oi_170059.pdf

Reference28 articles.

1. Acute myeloid leukemia: epidemiology and etiology.;Deschler;Cancer,2006

2. The changing prevalence of comorbidity across the age spectrum.;Piccirillo;Crit Rev Oncol Hematol,2008

3. Gait speed and survival in older adults.;Studenski;JAMA,2011

4. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia.;Klepin;Blood,2013

5. Age and acute myeloid leukemia.;Appelbaum;Blood,2006

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shikonin, a natural naphthoquinone phytochemical, exerts anti-leukemia effects in human CBF-AML cell lines and zebrafish xenograft models;Biomedicine & Pharmacotherapy;2024-10

2. Geriatric assessment for the practicing clinician: The why, what, and how;CA: A Cancer Journal for Clinicians;2024-08-29

3. Venetoclax‐based non‐intensive induction followed by allogenic stem‐cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics;European Journal of Haematology;2024-08-11

4. Novel insights and therapeutic approaches in secondary AML;Frontiers in Oncology;2024-07-29

5. Breaking down frailty: Assessing vulnerability in acute myeloid leukemia;Blood Reviews;2024-07